Logo image of REP.DE

REPSOL SA (REP.DE) Stock Fundamental Analysis

FRA:REP - Deutsche Boerse Ag - ES0173516115 - Common Stock - Currency: EUR

13.19  -0.12 (-0.94%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to REP. REP was compared to 61 industry peers in the Oil, Gas & Consumable Fuels industry. REP may be in some trouble as it scores bad on both profitability and health. REP has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year REP was profitable.
REP had a positive operating cash flow in the past year.
REP had positive earnings in 4 of the past 5 years.
In the past 5 years REP always reported a positive cash flow from operatings.
REP.DE Yearly Net Income VS EBIT VS OCF VS FCFREP.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B 8B

1.2 Ratios

REP has a worse Return On Assets (1.13%) than 75.41% of its industry peers.
REP's Return On Equity of 2.80% is on the low side compared to the rest of the industry. REP is outperformed by 75.41% of its industry peers.
REP's Return On Invested Capital of 3.51% is on the low side compared to the rest of the industry. REP is outperformed by 68.85% of its industry peers.
The Average Return On Invested Capital over the past 3 years for REP is below the industry average of 13.73%.
The 3 year average ROIC (8.89%) for REP is well above the current ROIC(3.51%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 1.13%
ROE 2.8%
ROIC 3.51%
ROA(3y)4.91%
ROA(5y)2.45%
ROE(3y)11.61%
ROE(5y)5.85%
ROIC(3y)8.89%
ROIC(5y)N/A
REP.DE Yearly ROA, ROE, ROICREP.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

REP's Profit Margin of 1.21% is on the low side compared to the rest of the industry. REP is outperformed by 73.77% of its industry peers.
REP's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 3.49%, REP is doing worse than 75.41% of the companies in the same industry.
REP's Operating Margin has been stable in the last couple of years.
REP has a worse Gross Margin (22.66%) than 77.05% of its industry peers.
REP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.49%
PM (TTM) 1.21%
GM 22.66%
OM growth 3Y-24.67%
OM growth 5Y-0.14%
PM growth 3Y-15.4%
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y0.75%
REP.DE Yearly Profit, Operating, Gross MarginsREP.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

3

2. Health

2.1 Basic Checks

REP has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for REP has been reduced compared to 1 year ago.
REP has less shares outstanding than it did 5 years ago.
REP has a worse debt/assets ratio than last year.
REP.DE Yearly Shares OutstandingREP.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
REP.DE Yearly Total Debt VS Total AssetsREP.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

REP has an Altman-Z score of 1.81. This is a bad value and indicates that REP is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of REP (1.81) is comparable to the rest of the industry.
The Debt to FCF ratio of REP is 7.47, which is on the high side as it means it would take REP, 7.47 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 7.47, REP perfoms like the industry average, outperforming 52.46% of the companies in the same industry.
REP has a Debt/Equity ratio of 0.36. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of REP (0.36) is better than 65.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 7.47
Altman-Z 1.81
ROIC/WACC0.54
WACC6.49%
REP.DE Yearly LT Debt VS Equity VS FCFREP.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

REP has a Current Ratio of 1.23. This is a normal value and indicates that REP is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.23, REP is not doing good in the industry: 67.21% of the companies in the same industry are doing better.
A Quick Ratio of 0.95 indicates that REP may have some problems paying its short term obligations.
REP has a worse Quick ratio (0.95) than 68.85% of its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 0.95
REP.DE Yearly Current Assets VS Current LiabilitesREP.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2

3. Growth

3.1 Past

The earnings per share for REP have decreased strongly by -41.18% in the last year.
REP shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 18.66% yearly.
REP shows a decrease in Revenue. In the last year, the revenue decreased by -8.73%.
REP shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.98% yearly.
EPS 1Y (TTM)-41.18%
EPS 3Y18.66%
EPS 5YN/A
EPS Q2Q%-12.86%
Revenue 1Y (TTM)-8.73%
Revenue growth 3Y4.72%
Revenue growth 5Y2.98%
Sales Q2Q%-8.3%

3.2 Future

Based on estimates for the next years, REP will show a small growth in Earnings Per Share. The EPS will grow by 0.42% on average per year.
The Revenue is expected to decrease by -0.49% on average over the next years.
EPS Next Y-16.55%
EPS Next 2Y-3.92%
EPS Next 3Y0.36%
EPS Next 5Y0.42%
Revenue Next Year-1.39%
Revenue Next 2Y-2.19%
Revenue Next 3Y-0.49%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
REP.DE Yearly Revenue VS EstimatesREP.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B
REP.DE Yearly EPS VS EstimatesREP.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 6.28 indicates a rather cheap valuation of REP.
85.25% of the companies in the same industry are more expensive than REP, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.41, REP is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 5.31, the valuation of REP can be described as very cheap.
Based on the Price/Forward Earnings ratio, REP is valued cheaper than 91.80% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 33.87. REP is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 6.28
Fwd PE 5.31
REP.DE Price Earnings VS Forward Price EarningsREP.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

72.13% of the companies in the same industry are more expensive than REP, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of REP indicates a somewhat cheap valuation: REP is cheaper than 62.30% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 10.08
EV/EBITDA 3.29
REP.DE Per share dataREP.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.92%
EPS Next 3Y0.36%

6

5. Dividend

5.1 Amount

REP has a Yearly Dividend Yield of 5.95%, which is a nice return.
Compared to an average industry Dividend Yield of 61.55, REP pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.39, REP pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.95%

5.2 History

The dividend of REP is nicely growing with an annual growth rate of 32.62%!
Dividend Growth(5Y)32.62%
Div Incr Years4
Div Non Decr Years4
REP.DE Yearly Dividends per shareREP.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

REP pays out 182.19% of its income as dividend. This is not a sustainable payout ratio.
The dividend of REP is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP182.19%
EPS Next 2Y-3.92%
EPS Next 3Y0.36%
REP.DE Yearly Income VS Free CF VS DividendREP.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B
REP.DE Dividend Payout.REP.DE Dividend Payout, showing the Payout Ratio.REP.DE Dividend Payout.PayoutRetained Earnings

REPSOL SA

FRA:REP (8/11/2025, 7:00:00 PM)

13.19

-0.12 (-0.94%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)07-24 2025-07-24/dmh
Earnings (Next)10-06 2025-10-06/bmo
Inst Owners23.62%
Inst Owner ChangeN/A
Ins Owners0.13%
Ins Owner ChangeN/A
Market Cap15.27B
Analysts70
Price Target14.25 (8.04%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.95%
Yearly Dividend0.97
Dividend Growth(5Y)32.62%
DP182.19%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)25.42%
Min EPS beat(2)2.4%
Max EPS beat(2)48.44%
EPS beat(4)3
Avg EPS beat(4)15.28%
Min EPS beat(4)-7.85%
Max EPS beat(4)48.44%
EPS beat(8)6
Avg EPS beat(8)16.6%
EPS beat(12)9
Avg EPS beat(12)16.65%
EPS beat(16)13
Avg EPS beat(16)14.46%
Revenue beat(2)0
Avg Revenue beat(2)-0.56%
Min Revenue beat(2)-0.6%
Max Revenue beat(2)-0.51%
Revenue beat(4)0
Avg Revenue beat(4)-4.76%
Min Revenue beat(4)-9.59%
Max Revenue beat(4)-0.51%
Revenue beat(8)1
Avg Revenue beat(8)-5.34%
Revenue beat(12)2
Avg Revenue beat(12)-6.89%
Revenue beat(16)3
Avg Revenue beat(16)-6.76%
PT rev (1m)4.21%
PT rev (3m)2.8%
EPS NQ rev (1m)25.16%
EPS NQ rev (3m)6.76%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)13.15%
Revenue NQ rev (3m)5.63%
Revenue NY rev (1m)1.09%
Revenue NY rev (3m)1.09%
Valuation
Industry RankSector Rank
PE 6.28
Fwd PE 5.31
P/S 0.28
P/FCF 10.08
P/OCF 2.78
P/B 0.64
P/tB 0.73
EV/EBITDA 3.29
EPS(TTM)2.1
EY15.92%
EPS(NY)2.48
Fwd EY18.83%
FCF(TTM)1.31
FCFY9.92%
OCF(TTM)4.75
OCFY35.98%
SpS47.64
BVpS20.59
TBVpS18.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.13%
ROE 2.8%
ROCE 4.7%
ROIC 3.51%
ROICexc 4.2%
ROICexgc 4.6%
OM 3.49%
PM (TTM) 1.21%
GM 22.66%
FCFM 2.75%
ROA(3y)4.91%
ROA(5y)2.45%
ROE(3y)11.61%
ROE(5y)5.85%
ROIC(3y)8.89%
ROIC(5y)N/A
ROICexc(3y)11.29%
ROICexc(5y)N/A
ROICexgc(3y)12.06%
ROICexgc(5y)N/A
ROCE(3y)11.91%
ROCE(5y)N/A
ROICexcg growth 3Y-35.12%
ROICexcg growth 5Y-0.05%
ROICexc growth 3Y-33.47%
ROICexc growth 5Y0.93%
OM growth 3Y-24.67%
OM growth 5Y-0.14%
PM growth 3Y-15.4%
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y0.75%
F-Score5
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 7.47
Debt/EBITDA 1.81
Cap/Depr 143.15%
Cap/Sales 7.21%
Interest Coverage 4.57
Cash Conversion 116.8%
Profit Quality 226.8%
Current Ratio 1.23
Quick Ratio 0.95
Altman-Z 1.81
F-Score5
WACC6.49%
ROIC/WACC0.54
Cap/Depr(3y)161.65%
Cap/Depr(5y)133.06%
Cap/Sales(3y)6.75%
Cap/Sales(5y)5.95%
Profit Quality(3y)62.72%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-41.18%
EPS 3Y18.66%
EPS 5YN/A
EPS Q2Q%-12.86%
EPS Next Y-16.55%
EPS Next 2Y-3.92%
EPS Next 3Y0.36%
EPS Next 5Y0.42%
Revenue 1Y (TTM)-8.73%
Revenue growth 3Y4.72%
Revenue growth 5Y2.98%
Sales Q2Q%-8.3%
Revenue Next Year-1.39%
Revenue Next 2Y-2.19%
Revenue Next 3Y-0.49%
Revenue Next 5YN/A
EBIT growth 1Y-58.35%
EBIT growth 3Y-21.11%
EBIT growth 5Y2.83%
EBIT Next Year44.63%
EBIT Next 3Y16.29%
EBIT Next 5Y10.56%
FCF growth 1Y-66.68%
FCF growth 3Y-55.78%
FCF growth 5Y-31.76%
OCF growth 1Y-37.25%
OCF growth 3Y2.01%
OCF growth 5Y0.47%